METHERGINE(METHYLERGONOVINE MALEATE) - 美国FDA药品数据库

药品名称	METHERGINE
申请号	006035	产品号	004
活性成分	METHYLERGONOVINE MALEATE	市场状态	处方药
剂型或给药途径	INJECTABLE;INJECTION	规格	0.2MG/ML
治疗等效代码	AP	参比药物	是
批准日期	Approved Prior to Jan 1, 1982	申请机构	EDISON THERAPEUTICS LLC
化学类型		审评分类

与本品相关的专利信息（来自橙皮书Orange Book）
专利号	专利过期日	是否化合物专利	是否产品专利	专利用途代码	专利下载
无
历史专利信息
无

与本品相关的市场独占权保护信息
独占权代码	失效日期
无
历史市场独占权保护信息
无

与药品注册相关的信息
申请号	修订号	审批结论	公开文档类型	文档创建时间	获取文档
006035	078	AP	Label	2012/06/25	下载
006035	078	AP	Letter	2012/06/27	下载
006035	078	AP	Review	2013/01/28	下载
006035	075	AP	Label	2007/05/01	下载
006035	075	AP	Letter	2007/05/01	下载
006035	073	AP	Letter	2003/10/09	下载
006035	072	AP	Letter	2004/03/02	下载

药品注册审批历史信息
申请号	修订号	审批结论	审批日期	审批内容
006035	079	AP	2013/05/21	Manufacturing Change or Addition
006035	078	AP	2012/06/25	Approval
006035	075	AP	2007/04/26	Labeling Revision
006035	073	AP	2003/10/01	Labeling Revision
006035	072	AP	2004/02/18	Labeling Revision
006035	069	AP	2002/02/05	Manufacturing Change or Addition
006035	068	AP	2002/02/05	Manufacturing Change or Addition
006035	067	AP	2002/01/28	Manufacturing Change or Addition
006035	066	AP	2001/04/03	Manufacturing Change or Addition
006035	065	AP	2001/05/22	Control Supplement
006035	064	AP	2000/04/14	Manufacturing Change or Addition
006035	063	AP	1999/12/09	Manufacturing Change or Addition
006035	062	AP	1999/04/22	Package Change
006035	061	AP	1997/07/15	Control Supplement
006035	060	AP	1997/05/27	Labeling Revision
006035	059	AP	1996/02/21	Manufacturing Change or Addition
006035	058	AP	1996/02/22	Labeling Revision
006035	057	AP	1995/10/17	Control Supplement
006035	056	AP	1995/09/22	Control Supplement
006035	055	AP	1995/09/22	Package Change
006035	054	AP	1994/07/07	Package Change
006035	053	AP	1993/03/11	Manufacturing Change or Addition
006035	052	AP	1994/04/25	Labeling Revision
006035	051	AP	1994/07/18	Formulation Revision
006035	050	AP	1995/03/22	Labeling Revision
006035	049	AP	1991/05/28	Labeling Revision
006035	048	AP	1990/09/06	Control Supplement
006035	047	AP	1989/10/20	Control Supplement
006035	046	AP	1989/10/20	Manufacturing Change or Addition
006035	044	AP	1989/10/20	Control Supplement
006035	043	AP	1989/10/20	Formulation Revision
006035	042	AP	1989/03/02	Formulation Revision
006035	037	AP	1987/05/06	Labeling Revision
006035	036	AP	1987/07/06	Control Supplement
006035	034	AP	1986/01/07	Labeling Revision
006035	033	AP	1985/05/14	Formulation Revision
006035	032	AP	1985/06/18	Control Supplement
006035	031	AP	1985/09/30	Practioner Draft Labeling
006035	030	AP	1984/08/30	Control Supplement
006035	029	AP	1984/10/22	Control Supplement
006035	025	AP	1981/06/15	Manufacturing Change or Addition
006035	024	AP	1981/06/17	Control Supplement
006035	023	AP	1981/09/28	Control Supplement
006035	022	AP	1981/06/17	General Efficacy (MarkIV)
006035	021	AP	1980/07/22	General Efficacy (MarkIV)
006035	020	AP	1979/05/15	General Efficacy (MarkIV)
006035	019	AP	1979/01/23	General Efficacy (MarkIV)
006035	018	AP	1979/01/16	Control Supplement
006035	016	AP	1977/06/09	Package Change
006035	013	AP	1976/05/03	Control Supplement
006035	012	AP	1976/01/16	Control Supplement
006035	011	AP	1975/05/20	Control Supplement
006035	010	AP	1975/05/20	Control Supplement
006035	000	AP	1946/11/19	Approval

返回检索页面